Myomo Inc (MYO)
Official siteHEALTHCARE • MEDICAL DEVICES • AMEX
Market Cap: $49.32M
Last updated: Nov 17, 2026 at 11:05 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 24.1% below its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 36.2, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about MYO
Government Contracts
Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies
Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.
News
MYO Valuation
MYO Profitability: Margins, ROIC and FCF
Myomo (MYO) has a gross margin of 70.1%, an operating margin of -19.3% and a net margin of -33.5%. It posts -51.9% ROIC and a -16.7% FCF margin.
- Gross margin
- 70.1%
- Operating margin
- -19.3%
- Net margin
- -33.5%
- ROIC
- -51.9%
- ROE
- -123.8%
- FCF margin
- -16.7%
- FCF yield
- -16.9%
Myomo Competitors
The companies most similar to Myomo (MYO) include Microbot Medical, Envoy Medical and Electrocore LLC.
Sector: Healthcare
Companies most similar to MyomoMYO Analyst Ratings
Myomo (MYO) has a Buy consensus from 5 analysts: 5 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 5
- Strong Buy
- 1
- Buy
- 4
- Hold
- 0
- Sell
- 0
- Strong Sell
- 0
MYO Bull Case vs Bear Case
Bull case
- MYO grew quarterly revenue 21.3% year over year.
- 100.0% of MYO's analyst ratings are Buy or Strong Buy.
Bear case
- MYO has a -33.5% net profit margin.
- MYO has a debt-to-equity ratio of 7.5x.
MYO Earnings: Beat Rate and Next Report
Myomo (MYO) beat the EPS estimate in 5 of the last 8 quarters (62.5%). Its next report is confirmed on Mar 8, 2027.
- Beat rate
- 5 of 8 quarters (62.5%)
- Average surprise
- 16.8%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.07
MYO Earnings Date
MYO reports Mar 8, 2027, after the close. The date is confirmed.
MYO Earnings Call
The latest MYO earnings call transcript on file is labeled 2026Q1.
Read the 2026Q1 transcriptMYO ETF Holders
GNG tracks 5 ETFs that hold MYO. The largest weights:
- iShares Russell 2000 ETF (IWM), <0.01% of the fund
- Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), <0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About MYO
When does MYO report earnings?
Myomo Inc (MYO) is confirmed to report earnings on Mar 8, 2027.
Does MYO pay dividends?
Myomo Inc (MYO) does not currently pay a regular dividend.
What is MYO's market cap?
Myomo Inc (MYO) has a market capitalization of $49.32M with a current stock price of $1.03.
MYO pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.